Science Explorer Back to mapMap
Discussion
Nonprofit · Munich · Germany

Rotkreuzklinikum München

In research, Rotkreuzklinikum München stands highest in Medicine (#5,713 of 14,558 worldwide) and Health Sciences (#6,683 of 16,688 worldwide), over all time.

rotkreuzklinikum-muenchen.deROR OpenAlex
World rank, all time
#23,763
of 34,923
Rank in Germany
#1,162
of 1,603
Research works
215
▼ 29% vs 2018-21
Citations
1.7k
7.9 per fractional work
Top-10% rate
5.2%
all institutions 10.0%
vs its own fields
1.01×
1.00× is exactly expected
Open access
17%
world 40%
International
15%
world 18%
Rotkreuzklinikum München

What is Rotkreuzklinikum München known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #5,713 of 14,558 4.6%151
Health SciencesDomain #6,683 of 16,688 4.6%160

Each strip is that field's whole ranked pool, with the notch where Rotkreuzklinikum München sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Rotkreuzklinikum München work in?

In 2022-now, 74% of research at Rotkreuzklinikum München is in Health Sciences, 12% in Life Sciences. Its largest fields are Medicine (72%), Biochemistry, Genetics and Molecular Biology (8%), Business, Management and Accounting (5%). It does 2.7× the world's share of Health Sciences.

Health Sciences: 34 fractional works · 73.9% of its workMedicine: 33 fractional works · 71.6% of its workOncology: 8 fractional works · 17.6% of its workSurgery: 6 fractional works · 14.0% of its workPathology and Forensic Medicine: 2 fractional works · 5.0% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 4.5% of its workReproductive Medicine: 2 fractional works · 4.1% of its workEpidemiology: 2 fractional works · 3.8% of its workPulmonary and Respiratory Medicine: 2 fractional works · 3.7% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 3.2% of its workRheumatology: 1 fractional works · 1.9% of its workObstetrics and Gynecology: 1 fractional works · 1.8% of its workDermatology: 1 fractional works · 1.7% of its workGenetics: 1 fractional works · 1.5% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.2% of its workHematology: 1 fractional works · 1.2% of its workPsychiatry and Mental health: 0 fractional works · 1.1% of its workOtorhinolaryngology: 0 fractional works · 0.7% of its workOphthalmology: 0 fractional works · 0.6% of its workEmergency Medicine: 0 fractional works · 0.6% of its workNeurology: 0 fractional works · 0.6% of its workNephrology: 0 fractional works · 0.4% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.4% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.3% of its workGeriatrics and Gerontology: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.3% of its workInfectious Diseases: 0 fractional works · 0.2% of its workPhysiology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.6% of its workHealth Professions: 1 fractional works · 1.7% of its workGeneral Health Professions: 1 fractional works · 1.3% of its workEmergency Medical Services: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDentistry: 0 fractional works · 0.4% of its workOrthodontics: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workVeterinary: 0 fractional works · 0.3% of its workLife Sciences: 5 fractional works · 11.6% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 8.3% of its workCancer Research: 2 fractional works · 4.1% of its workMolecular Biology: 2 fractional works · 3.5% of its workGenetics: 0 fractional works · 0.2% of its workPhysiology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 1 fractional works · 1.8% of its workNeurology: 0 fractional works · 0.7% of its workSensory Systems: 0 fractional works · 0.7% of its workBehavioral Neuroscience: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 1 fractional works · 1.4% of its workImmunology: 1 fractional works · 1.4% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.0% of its workSocial Sciences: 5 fractional works · 10.3% of its workBusiness, Management and Accounting: 2 fractional works · 4.8% of its workStrategy and Management: 1 fractional works · 1.7% of its workOrganizational Behavior and Human Resource Management: 1 fractional works · 1.7% of its workAccounting: 1 fractional works · 1.4% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.5% of its workFinance: 0 fractional works · 1.1% of its workEconomics and Econometrics: 0 fractional works · 0.4% of its workSocial Sciences: 1 fractional works · 1.4% of its workSociology and Political Science: 0 fractional works · 0.6% of its workEducation: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPsychology: 1 fractional works · 1.3% of its workSocial Psychology: 0 fractional works · 0.8% of its workClinical Psychology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.0% of its workArts and Humanities: 1 fractional works · 1.2% of its workLiterature and Literary Theory: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.5% of its workPhysical Sciences: 2 fractional works · 4.1% of its workEngineering: 1 fractional works · 2.4% of its workArchitecture: 0 fractional works · 1.1% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workComputational Mechanics: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.5% of its workComputer Science: 1 fractional works · 1.6% of its workArtificial Intelligence: 0 fractional works · 0.7% of its workSignal Processing: 0 fractional works · 0.5% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.4% of its workChemistry: 0 fractional works · 0.0% of its workMathematics: 0 fractional works · 0.0% of its workALL ITS WORKRotkreuzklinikumMünchen46fractional works, 2022-now
Life Sciences12%Physical Sciences4%Health Sciences74%Social Sciences10%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 18 fields, with their numbers
    1. Medicine3371.6%
    2. Health Professions11.7%
    3. Dentistry00.4%
    4. Veterinary00.3%
    1. Biochemistry, Genetics and Molecular Biology48.3%
    2. Neuroscience11.8%
    3. Immunology and Microbiology11.4%
    4. Pharmacology, Toxicology and Pharmaceutics00.0%
    1. Business, Management and Accounting24.8%
    2. Economics, Econometrics and Finance11.5%
    3. Social Sciences11.4%
    4. Psychology11.3%
    5. Arts and Humanities11.2%
    1. Engineering12.4%
    2. Computer Science11.6%
    3. Chemistry00.0%
    4. Mathematics00.0%
    5. Environmental Science00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.56× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 1.44× its world share, 1 worksImmunology and Micro…Neuroscience: 1.12× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.10× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.03× its world share, 0 worksChemistryComputer Science: 0.20× its world share, 1 worksComputer ScienceEngineering: 0.16× its world share, 1 worksEngineeringEnvironmental Science: 0.01× its world share, 0 worksEnvironmental ScienceMathematics: 0.04× its world share, 0 worksMathematicsDentistry: 0.81× its world share, 0 worksDentistryHealth Professions: 0.64× its world share, 1 worksHealth ProfessionsMedicine: 3.72× its world share, 33 worksMedicineVeterinary: 2.12× its world share, 0 worksVeterinaryArts and Humanities: 0.42× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 1.50× its world share, 2 worksBusiness, Management…Economics, Econometrics and Finance: 0.70× its world share, 1 worksEconomics, Econometr…Psychology: 0.44× its world share, 1 worksPsychologySocial Sciences: 0.12× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.7×. Every wedge is a field page.

All 18 fields, with their numbers
  1. Medicine3.72×33 works
  2. Veterinary2.12×0 works
  3. Biochemistry, Genetics and Molecular Biology1.56×4 works
  4. Business, Management and Accounting1.50×2 works
  5. Immunology and Microbiology1.44×1 works
  6. Neuroscience1.12×1 works
  7. Dentistry0.81×0 works
  8. Economics, Econometrics and Finance0.70×1 works
  9. Health Professions0.64×1 works
  10. Psychology0.44×1 works
  11. Arts and Humanities0.42×1 works
  12. Computer Science0.20×1 works
  13. Engineering0.16×1 works
  14. Social Sciences0.12×1 works
  15. Pharmacology, Toxicology and Pharmaceutics0.10×0 works
  16. Mathematics0.04×0 works
  17. Chemistry0.03×0 works
  18. Environmental Science0.01×0 works

Who are the top researchers at Rotkreuzklinikum München?

Ranked on the quality score, Claus Alexander Hanusch, Christian von Bary and Michaela Beer lead among researchers whose main affiliation is Rotkreuzklinikum München.

  1. 1 Claus Alexander Hanusch Germany · #78,234 worldwide 15k citations · 220 works
  2. 2 Christian von Bary Germany · #1,847,340 worldwide 1.3k citations · 55 works
  3. 3 Michaela Beer Germany · #2,346,681 worldwide 144 citations · 84 works
  4. 4 Michael Schoenberg Germany · #2,503,199 worldwide 441 citations · 21 works
  5. 5 Elena Bensmann Germany · #3,163,987 worldwide 103 citations · 18 works
  6. 6 Jörg Schilling Germany · #3,467,011 worldwide 274 citations · 19 works
  7. 7 Martin Pölcher Germany · #3,657,341 worldwide 3.2k citations · 118 works
  8. 8 Pilar Arrizabalaga Clemente Germany · #4,003,418 worldwide 50 citations · 17 works
  9. 9 Anne Andrulat Germany · #4,115,618 worldwide 96 citations · 24 works
  10. 10 Barbara Koller Germany · #4,472,965 worldwide 100 citations · 17 works
All ranked researchers at Rotkreuzklinikum München

What are the most cited papers from Rotkreuzklinikum München?

The most cited paper from Rotkreuzklinikum München is "Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy" (Carsten Denkert et al., 2017), with 2,205 citations. Next come "Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial" (1,048) and "A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study" (714).

Most cited papers
#PaperReleasedCitations
1 Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy Carsten Denkert et al. · The Lancet Oncology 8 Dec 2017 2,205
2 Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial Gϋnter von Minckwitz et al. · The Lancet Oncology 30 Apr 2014 1,048
3 A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study S. Loibl et al. · Annals of Oncology Open access 7 May 2019 714
4 Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials Carsten Denkert et al. · The Lancet Oncology 9 Jul 2021 581
5 Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial Michael Gnant, Brigitte Mlineritsch, Herbert Stoeger et al. · The Lancet Oncology 12 Jun 2011 474
All 60 most cited papers, with filters and sorting

Which keywords describe research at Rotkreuzklinikum München?

By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Metastasis, Radiotherapy, Survival Analysis, Complications, Quality of Life, Clinical Practice Guidelines and Breast Cancer.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy5▲ 15×13 topics
  2. Metastasis4▲ 24×5 topics
  3. Radiotherapy4▲ 20×5 topics
  4. Quality of Life3▲ 5.1×10 topics
  5. Epidemiology3▲ 1.74×23 topics
  6. Complications3▲ 13×8 topics
  7. Survival Analysis3▲ 24×5 topics
  8. Clinical Practice Guidelines3▲ 11×8 topics
  9. Breast Cancer3▲ 23×6 topics
  10. Molecular Subtypes3▲ 63×3 topics
  11. Clinical Trials2▲ 8.2×7 topics
  12. Genomic Analysis2▲ 21×2 topics
  13. Biomarkers2▲ 6.5×5 topics
  14. Immunohistochemistry2▲ 66×3 topics
  15. Cancer2▲ 3.1×12 topics
  16. Breast Reconstruction2▲ 67×2 topics
  17. Cytoreductive Surgery2▲ 63×1 topic
  18. Ovarian Cancer2▲ 45×2 topics
  19. Tumor Models2▲ 69×1 topic
  20. Prognostic Factors2▲ 8.8×9 topics
  21. Acellular Dermal Matrix2▲ 173×1 topic
  22. Clinical Management2▲ 21×2 topics
  23. Gene Expression Profiling2▲ 48×2 topics
  24. Immunotherapy2▲ 5.2×10 topics
  25. Molecular Profiling2▲ 39×2 topics
  26. Neoadjuvant Therapy2▲ 16×4 topics
  27. Patient-Reported Outcome Measure2▲ 173×1 topic
  28. Breast Tumours2▲ 69×1 topic
  29. Corporate Governance2▲ 4.6×5 topics
  30. Gene Expression2▲ 5.6×3 topics
  31. Prognostic Markers2▲ 31×2 topics
  32. Treatment Response2▲ 69×1 topic
  33. Cancer of Unknown Primary1▲ 115×1 topic
  34. Health-related Quality of Life1▲ 12×5 topics
  35. Tissue of Origin1▲ 115×1 topic
  36. Tumor Microenvironment1▲ 6.5×5 topics
  37. Synthetic Lethality1▲ 74×2 topics
  38. Sentinel Lymph Node Biopsy1▲ 29×2 topics
  39. Biopsy1▲ 38×2 topics
  40. Mammography1▲ 106×1 topic

Which research topics does Rotkreuzklinikum München publish most on?

By volume in 2022-now: Ovarian cancer diagnosis and treatment, Breast Implant and Reconstruction, Breast Cancer Treatment Studies and Cancer Diagnosis and Treatment.

Ovarian cancer diagnosis…2Ovarian cancer diagnosis and treatment: 2 fractional worksBreast Implant and Recon…2Breast Implant and Reconstruction: 2 fractional worksBreast Cancer Treatment …2Breast Cancer Treatment Studies: 2 fractional worksCancer Diagnosis and Tre…1Cancer Diagnosis and Treatment: 1 fractional worksBreast Lesions and Carcinomas: 1 fractional worksHER2/EGFR in Cancer Research: 1 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksDigital Imaging in Medicine: 1 fractional worksCancer survivorship and care: 1 fractional worksCorporate Governance and Management: 1 fractional works
Reproductive MedicineSurgeryCancer ResearchOncology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Ovarian cancer diagnosis and treatment Reproductive Medicine 2 works
  2. 2 Breast Implant and Reconstruction Surgery 2 works
  3. 3 Breast Cancer Treatment Studies Cancer Research 2 works
  4. 4 Cancer Diagnosis and Treatment Oncology 1 works
  5. 5 Breast Lesions and Carcinomas Pathology and Forensic Medicine 1 works
  6. 6 HER2/EGFR in Cancer Research Oncology 1 works
  7. 7 Cancer Immunotherapy and Biomarkers Oncology 1 works
  8. 8 Digital Imaging in Medicine Public Health, Environmental and Occupational Health 1 works
  9. 9 Cancer survivorship and care Oncology 1 works
  10. 10 Corporate Governance and Management Strategy and Management 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available17.0%not open83.0%

World: 40% of research is openly available.

with international co-authors15.2%domestic only84.8%

World: 18% is written across borders.

How has Rotkreuzklinikum München's research output changed?

Output in 2022-2025 was 29% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Rotkreuzklinikum München as a percentage of every work published that year, 0.00015% in 2024.

still counting0.00050%0.0010%Rotkreuzklinikum München0.00020% in 202519801990200020102020

Fractional works of Rotkreuzklinikum München over all fractional works that year. How the balance of science has shifted.

Other research institutions in Munich

All research institutions in Munich

Share Rotkreuzklinikum München's ranking

Rotkreuzklinikum München on Science Explorer

A card with Rotkreuzklinikum München's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Rotkreuzklinikum München. Posts are plain text and can be reported.